SM
LUMO

Sabby Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Sabby Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-111
Closed -$1.02M – 190
2017
Q3 		$1.02M Buy
+111
New +$8.51K 0.07% 72
2017
Q2 		– Sell
-268
Closed -$5.82M – 265
2017
Q1 		$5.82M Buy
268
+92
+52% +$13.1K 0.31% 44
2016
Q4 		$1.62M Sell
176
-145
-45% -$16.3K 0.09% 118
2016
Q3 		$4.34M Sell
321
-320
-50% -$31.8K 0.16% 83
2016
Q2 		$3.46M Buy
641
+435
+211% +$53.9K 0.18% 71
2016
Q1 		$3.37M Sell
206
-42
-17% -$8.51K 0.17% 62
2015
Q4 		$8.12M Sell
248
-163
-40% -$53.1K 0.45% 38
2015
Q3 		$13.3M Buy
411
+64
+18% +$28.1K 0.55% 31
2015
Q2 		$13.8M Sell
347
-102
-23% -$43.3K 0.5% 40
2015
Q1 		$22.1M Buy
+449
New +$174K 0.92% 26
2014
Q3 		– Sell
-110
Closed -$2.62M – 303
2014
Q2 		$2.62M Sell
110
-76
-41% -$15.5K 0.11% 87
2014
Q1 		$4.76M Sell
186
-356
-66% -$109K 0.27% 67
2013
Q4 		$10.7M Buy
542
+8
+1% +$1.42K 0.68% 33
2013
Q3 		$9.03M Buy
534
+93
+21% +$15K 0.59% 41
2013
Q2 		$7.83M Buy
+441
New +$62.4K 0.52% 44

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sabby Management's LUMO Position: Q3 2017 in Review

Sabby Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2017, closing a stake of 15,339 shares — an estimated $1.18M sold.

Sabby Management first reported a position in LUMO in Q2 2014 and held it in 8 quarters. The position peaked at $6.23M in Q4 2015. 126 funds tracked by Wall St. Rank hold LUMO as of Q3 2017.

  • Sabby Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Sabby Management sold 15,339 Lumos Pharma, Inc. Common Stock shares in Q3 2017, an estimated $1.18M.
  • Sabby Management first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2014 and held it in 8 quarters.
  • Sabby Management's Lumos Pharma, Inc. Common Stock position peaked at $6.23M in Q4 2015.
  • 126 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2017.

Based on Sabby Management's 13F filing for Q3 2017, filed 14 Nov 2017.